Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
DAWN
Stock Latest News
Company Announcements
Day One Biopharmaceuticals Reprices Stock Options for Retention
9d ago
8K
DAWN
Premium
The Fly
Day One Biopharmaceuticals management to meet with Piper Sandler
27d ago
DAWN
Premium
The Fly
Day One Biopharmaceuticals initiated with an Overweight at Piper Sandler
2M ago
DAWN
Premium
The Fly
Day One Biopharmaceuticals initiated with an Overweight at Piper Sandler
2M ago
DAWN
Premium
Ratings
Promising Growth and Stability Drive Buy Rating for Day One Biopharmaceuticals
2M ago
DAWN
Premium
Company Announcements
Day One Biopharma’s Earnings Call Highlights Growth and Strategy
2M ago
DAWN
Premium
Ratings
Promising Growth and Strategic Innovation Drive Buy Rating for Day One Biopharmaceuticals
2M ago
DAWN
Premium
Ratings
Buy Rating for Day One Biopharmaceuticals Amid Promising Future Catalysts Despite Current Challenges
2M ago
DAWN
Premium
The Fly
Day One Biopharmaceuticals price target lowered to $17 from $20 at BofA
2M ago
DAWN
Premium
The Fly
Day One price target lowered to $25 from $36 at H.C. Wainwright
2M ago
DAWN
Premium
Company Announcements
Day One Biopharma Reports Strong Q2 2025 Growth
2M ago
DAWN
Premium
Company Announcements
Day One Biopharmaceuticals Reports Strong Q2 2025 Results
2M ago
8K
DAWN
Premium
The Fly
Day One Biopharmaceuticals reports Q2 EPS (29c), consensus (34c)
2M ago
DAWN
Premium
The Fly
Day One Biopharmaceuticals appoints Michael Vasconcelles as Head of R&D
4M ago
DAWN
Premium
Company Announcements
Day One Biopharmaceuticals Approves Key Proposals at Annual Meeting
5M ago
8K
DAWN
Premium
Ratings
Positive Outlook for Day One Biopharmaceuticals’ Ojemda: A Promising First-Line Treatment for Pediatric Glioma
5M ago
DAWN
Premium
Ratings
Buy Rating for Day One Biopharmaceuticals Driven by FDA Approval and Strong Market Potential
5M ago
DAWN
Premium
Ratings
Promising Future for Day One Biopharmaceuticals: Buy Rating on Ojemda’s Potential in Pediatric Brain Tumors
5M ago
DAWN
Premium
Company Announcements
Day One Biopharma’s Earnings Call Highlights Growth
5M ago
DAWN
Premium
The Fly
Day One price target lowered to $26 from $30 at JonesResearch
5M ago
DAWN
Premium
Ratings
Day One Biopharmaceuticals: A Compelling Buy Amidst Growth Potential and Strong Financial Position
5M ago
DAWN
Premium
Ratings
Positive Outlook for Day One Biopharmaceuticals Despite Seasonal Challenges, Buy Rating Reaffirmed
6M ago
DAWN
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
